RxDoctor Payments Data

Kelli Baker

Nurse Practitioner · Canton, OHNPI 1255880779

Payments from drug & device makers

$2,587in general payments, 2019–2025

Across 153 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$258
  • Novo Nordisk$242
  • Novartis$188
  • Abbott$149
  • Xeris Pharmaceuticals, Inc.$131
  • Boehringer Ingelheim$119
  • plus $1K from 36 others

What the payments were for

  • Food & beverage$2,587100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,587 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$7,896
Medicare patients
25
Services billed
115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin179$152,439
OzempicSemaglutide121$133,181
TrulicityDulaglutide70$92,514
MounjaroTirzepatide46$48,792
Humulin R U-500 KwikpenInsulin Regular, Human29$32,145
Tresiba Flextouch U-200Insulin Degludec25$26,491
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog37$22,374
TradjentaLinagliptin24$19,251
FarxigaDapagliflozin Propanediol21$14,557
VascepaIcosapent Ethyl30$12,355
Humalog Kwikpen U-100Insulin Lispro40$12,279
RybelsusSemaglutide12$11,350
JanuviaSitagliptin Phosphate12$9,690
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$8,602
Lantus SolostarInsulin Glargine,hum.Rec.Anlog71$7,656

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$119$171,690203 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog$258$148,021137 claims
Novo NordiskOzempic, Rybelsus$242$144,531133 claims
AstraZenecaFarxiga$42$14,55721 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$35$2,533256 claims
AbbVieSynthroid$15$1,87243 claims
Sanofi-aventis U.S. LLCLantus$114$1,39413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →